Intensive Care News and Research

RSS

Radiometer launches the next generation of transcutaneous monitoring in Canada

Radiometer has unveiled its Health Canada licensed TCM5 transcutaneous monitor, addressing the critical care needs of neonatal, pediatric, and adult patients, as well as sleep clinic

From Radiometer Medical 9 Jun 2021

SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

The report, published in the journal Clinical Infectious Diseases, revealed that the variant detected has been spreading at an alarming rate since November. By February 2021, it accounted for 12.3 percent of all cases in the area.

8 Jun 2021

Researchers find new insight on the link between a gene and congenital heart disease

New insight on the link between a gene called SORBS2 and congenital heart disease has been published today in eLife, with findings that may help explain the cause of the disease in some patients.

8 Jun 2021

Treating critically ill COVID-19 patients with non-altered umbilical cord stem cells increases survival

Critically ill COVID-19 patients treated with non-altered stem cells from umbilical cord connective tissue were more than twice as likely to survive as those who did not have the treatment, according to a study published today in STEM CELLS Translational Medicine.

8 Jun 2021

Efforts to reduce patients' time on ventilator can spare their suffering and free up ICU resources

More active efforts to reduce patients' time on a ventilator in an ICU can both spare their suffering and free up intensive care resources, a thesis at the University of Gothenburg shows.

8 Jun 2021

Link between SARS-CoV-2 organotropism and kidney injury

It was clear at a relatively early stage of the pandemic that SARS-CoV-2 causes a wide range of symptoms; in addition to typical respiratory symptoms, patients also had neurological symptoms (starting with anosmia), gastrointestinal symptoms, elevated liver values, and renal, urinary or hematological changes, for example.

8 Jun 2021

New research identifies protein as therapeutic anti-viral target for COVID-19

New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new therapeutic anti-viral target.

7 Jun 2021

Repeated low-dose dose exposure to SARS-CoV-2 may protect against severe COVID-19

The Italian authors of this paper, published in the journal Viruses, have taken this hypothesis and expanded it to include viral particles suspended in the air or on inanimate objects as a possible source of T cell immunity due to the repeated low-dose exposure, potentially explaining virus immunity found in non-infected individuals.

7 Jun 2021

Chronic medical conditions could increase the risk of severe COVID-19 among children

...

7 Jun 2021

Patients with obesity at greater risk of developing long-term complications of COVID-19

A Cleveland Clinic study shows that survivors of COVID-19 who have moderate or severe obesity may have a greater risk of experiencing long-term consequences of the disease, compared with patients who do not have obesity.

3 Jun 2021

Ethnic minorities are twice as likely to die after traumatic brain injury

People of color are more than twice as likely to die after a traumatic brain injury as white people, according to a new retrospective review from Oregon Health & Science University.

2 Jun 2021

Long COVID patients at higher risk of small airway disease

The preprint discussed herein describes the effects of SARS-CoV-2 on lung structure and function in patients with long COVID.

2 Jun 2021

New insight into how platelets help resolve bacterial lung inflammation

Treating patients with acute respiratory failure is a constant challenge in intensive care medicine. In most cases, the underlying cause is lung inflammation triggered by a bacterial infection or - more rarely, despite being frequently observed at present due to the corona pandemic - a viral infection.

2 Jun 2021

Could higher carnitine levels in the blood protect against severe COVID-19?

Researchers at the MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK, found that carnitine and its derivative acetyl-carnitine provide a protective effect against severe COVID-19. Doubling of carnitine or acetyl-carnitine is tied to a 40-percent reduction risk of disease progression.

2 Jun 2021

The ‘grief pandemic’ will torment Americans for years

Cassandra Rollins' daughter was still conscious when the ambulance took her away.

2 Jun 2021

Childhood vaccination rates in Texas have dropped steeply during COVID-19 pandemic

A team of researchers from universities in California and Texas has found immunization rates for children in Texas for a wide range of diseases, including polio and measles, have dropped steeply during the COVID-19 pandemic.

2 Jun 2021

Using Sotrovimab to treat COVID-19 early

A new study published on the medRxiv* preprint server hypothesized that a monoclonal antibody that has the capability to neutralize all sarbecoviruses could also be used to target a highly conserved epitope. This conserved sequence has a high probability of remaining unchanged in SARS-CoV-2 variants.

31 May 2021

Researchers assess the prognostic value of cardiac troponin I in COVID-19 patients

Corona Virus Disease (COVID -19) patients primarily appear with respiratory issues and viral pneumonia. The patients may also present cardiovascular issues includes early signs of acute myocardial injury.

29 May 2021

New system can measure propofol concentration in patient's blood during surgery

Anesthesia may be an exact science, but it's not yet fully personalized. Anesthesiologists use a variety of methods to calculate the right dose for a given patient: clinical studies, medical databases and laboratory measurements, for example. However, every individual responds to anesthetics in a different way, and there's no way of knowing what that response will be until the anesthetic is administered.

29 May 2021

New biocompatible electrode prevents muscle loss in COVID-19 patients

A research group from Aarhus University has developed a special biocompatible electrode for electrical muscle stimulation that the group has integrated and 3D-printed onto medical support stockings.

29 May 2021

Intensive Care News and Research

Radiometer launches the next generation of transcutaneous monitoring in Canada

SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

Researchers find new insight on the link between a gene and congenital heart disease

Treating critically ill COVID-19 patients with non-altered umbilical cord stem cells increases survival

Efforts to reduce patients' time on ventilator can spare their suffering and free up ICU resources

Link between SARS-CoV-2 organotropism and kidney injury

New research identifies protein as therapeutic anti-viral target for COVID-19

Repeated low-dose dose exposure to SARS-CoV-2 may protect against severe COVID-19

Chronic medical conditions could increase the risk of severe COVID-19 among children

Patients with obesity at greater risk of developing long-term complications of COVID-19

Ethnic minorities are twice as likely to die after traumatic brain injury

Long COVID patients at higher risk of small airway disease

New insight into how platelets help resolve bacterial lung inflammation

Could higher carnitine levels in the blood protect against severe COVID-19?

The ‘grief pandemic’ will torment Americans for years

Childhood vaccination rates in Texas have dropped steeply during COVID-19 pandemic

Using Sotrovimab to treat COVID-19 early

Researchers assess the prognostic value of cardiac troponin I in COVID-19 patients

New system can measure propofol concentration in patient's blood during surgery

New biocompatible electrode prevents muscle loss in COVID-19 patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News